A. S. Bhardwaj, B. Mclellan, M. R. Robinson, O. Ghaw, L. R. Lipsey et al., A case of vasculitis in a breast cancer patient treated with T-DM1, Seminars in Oncology, vol.41, pp.39-45, 2014.

B. Dholaria and S. Srinivasan, T-DM1-related carotenoderma and hand-foot syndrome, Lancet, vol.385, pp.1509-1510, 2015.

Y. Ji, S. Chen, C. Xu, L. Li, and B. Xiang, The use of propranolol in the treatment of infantile haemangiomas: An update on potential mechanisms of action, The British Journal of Dermatology, vol.172, pp.24-32, 2015.

Y. Kwon, M. Gomberg-maitland, M. Pritzker, and T. Thenappan, Telangiectasia and pulmonary arterial hypertension following treatment with trastuzumab emtansine: A case report, Chest, vol.149, pp.103-105, 2016.

W. K. Pan, P. Li, Z. T. Guo, Q. Huang, and Y. Gao, Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway, Pediatric Blood & Cancer, vol.62, pp.1414-1420, 2015.

V. Sibaud, R. E. Niec, K. Schindler, K. J. Busam, H. Roché et al., Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: A case series, Breast Cancer Research and Treatment, vol.146, pp.451-456, 2014.

V. Sibaud, E. Vigarios, P. Combemale, L. Lamant, M. E. Lacouture et al., T-DM1-related telangiectasias: A potential role in secondary bleeding events, Annals of Oncology, vol.26, pp.436-437, 2015.

S. Verma, D. Miles, L. Gianni, I. E. Krop, M. Welslau et al., Trastuzumab emtansine for HER2-positive advanced breast cancer, The New England Journal of Medicine, vol.367, pp.1783-1791, 2012.

, FIGURE 2 (a) Telangiectasias on the left arm before treatment with propranolol, taking the appearance of spider angiomas in some locations